These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
881 related articles for article (PubMed ID: 28718981)
41. The cost-effectiveness of immunotherapy for respiratory allergy: a review. Simoens S Allergy; 2012 Sep; 67(9):1087-105. PubMed ID: 22765521 [TBL] [Abstract][Full Text] [Related]
42. Molecular approaches to allergen-specific immunotherapy: Are we so far from clinical implementation? Pechsrichuang P; Jacquet A Clin Exp Allergy; 2020 May; 50(5):543-557. PubMed ID: 32078207 [TBL] [Abstract][Full Text] [Related]
44. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Pajno GB; Fernandez-Rivas M; Arasi S; Roberts G; Akdis CA; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; Ebisawa M; Eigenmann P; Knol E; Nadeau KC; Poulsen LK; van Ree R; Santos AF; du Toit G; Dhami S; Nurmatov U; Boloh Y; Makela M; O'Mahony L; Papadopoulos N; Sackesen C; Agache I; Angier E; Halken S; Jutel M; Lau S; Pfaar O; Ryan D; Sturm G; Varga EM; van Wijk RG; Sheikh A; Muraro A; Allergy; 2018 Apr; 73(4):799-815. PubMed ID: 29205393 [TBL] [Abstract][Full Text] [Related]
45. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA. Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705 [TBL] [Abstract][Full Text] [Related]
46. Clinical outcomes of AIT in the elderly population. Bożek A Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):341-345. PubMed ID: 37357782 [TBL] [Abstract][Full Text] [Related]
47. Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies. Lam HY; Tergaonkar V; Ahn KS Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32186703 [TBL] [Abstract][Full Text] [Related]
48. Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews. Asamoah F; Kakourou A; Dhami S; Lau S; Agache I; Muraro A; Roberts G; Akdis C; Bonini M; Cavkaytar O; Flood B; Izuhara K; Jutel M; Kalayci Ö; Pfaar O; Sheikh A Clin Transl Allergy; 2017; 7():25. PubMed ID: 28775845 [TBL] [Abstract][Full Text] [Related]
49. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy. Roll A; Hofbauer G; Ballmer-Weber BK; Schmid-Grendelmeier P J Investig Allergol Clin Immunol; 2006; 16(2):79-85. PubMed ID: 16689180 [TBL] [Abstract][Full Text] [Related]
51. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. Burks AW; Calderon MA; Casale T; Cox L; Demoly P; Jutel M; Nelson H; Akdis CA J Allergy Clin Immunol; 2013 May; 131(5):1288-96.e3. PubMed ID: 23498595 [TBL] [Abstract][Full Text] [Related]
52. Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis. Kristiansen M; Dhami S; Netuveli G; Halken S; Muraro A; Roberts G; Larenas-Linnemann D; Calderón MA; Penagos M; Du Toit G; Ansotegui IJ; Kleine-Tebbe J; Lau S; Matricardi PM; Pajno G; Papadopoulos NG; Pfaar O; Ryan D; Santos AF; Timmermanns F; Wahn U; Sheikh A Pediatr Allergy Immunol; 2017 Feb; 28(1):18-29. PubMed ID: 27653623 [TBL] [Abstract][Full Text] [Related]
53. Responders and nonresponders to pharmacotherapy and allergen immunotherapy. Jakalski M; Bozek A; Canonica GW Hum Vaccin Immunother; 2019; 15(12):2896-2902. PubMed ID: 31070995 [TBL] [Abstract][Full Text] [Related]
54. Indonesia-Based Study of the Clinical and Cost-Saving Benefits of Subcutaneous Allergen Immunotherapy for Children with Allergic Rhinitis in Private Practice. Endaryanto A; Nugraha RA Cells; 2021 Jul; 10(7):. PubMed ID: 34360010 [TBL] [Abstract][Full Text] [Related]
55. New directions in immunotherapy. Cox L; Compalati E; Kundig T; Larche M Curr Allergy Asthma Rep; 2013 Apr; 13(2):178-95. PubMed ID: 23315329 [TBL] [Abstract][Full Text] [Related]
56. Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study. Florido-López JF; Andreu-Balaguer C; Escudero C; Seoane-Rodríguez M; Hernández M; Navarro-Seisdedos LÁ; Torrecillas-Toro M; Anton-Girones M; Herrero-Lifona L; Brugaletta D; Macías J; Pineda R; Lara MÁ; López-Caballero J; Rojas MJ World Allergy Organ J; 2020 Dec; 13(12):100487. PubMed ID: 33376572 [TBL] [Abstract][Full Text] [Related]
57. Cost-effectiveness analysis of grass pollen specific immunotherapy in children with allergic rhinitis compared to the standard of care symptomatic treatment in Portugal. Farraia M; Paciência I; Castro Mendes F; Cavaleiro Rufo J; Delgado L; Moreira A Eur Ann Allergy Clin Immunol; 2023 Sep; 55(5):212-228. PubMed ID: 34927406 [No Abstract] [Full Text] [Related]
58. Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases. Yang Y; Ma D; Huang N; Li W; Jiang Q; Wang Y; Wang X; Yang L; Zhu R Ital J Pediatr; 2021 Apr; 47(1):101. PubMed ID: 33892756 [TBL] [Abstract][Full Text] [Related]
59. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study. Schmitt J; Schwarz K; Stadler E; Wüstenberg EG J Allergy Clin Immunol; 2015 Dec; 136(6):1511-1516. PubMed ID: 26371838 [TBL] [Abstract][Full Text] [Related]
60. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective. Bousquet J; Jutel M; Pfaar O; Fonseca JA; Agache I; Czarlewski W; Bachert C; Bergmann KC; Cruz AA; Klimek L; Kvedariene V; Larenas-Linnemann DE; Papadopoulos NG; Patella V; Regateiro FS; Scichilone N; Shamji MH; Sheikh A; Valovirta E; Ventura MT; Zuberbier T J Allergy Clin Immunol Pract; 2021 May; 9(5):1805-1812. PubMed ID: 33662672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]